Mink Therapeutics develops a healthy donor's sample of iNKT cells into many infusions of natural iNKT treatments for patients with cancer and infectious diseases; an allogeneic process.
The infinity symbol represents the division of a curative cell, suggesting unbound replication of curative solutions.
With its bold INKT cells allogeneic approach, Mink Therapeutics IPO was launched to have a disruptive role in the IO space. The complementary red and light blue palette stands to express determination and uniqueness; a very differentiating statement.
Style manual. Rebranding of Agenus' INKTs subsidiary for IPO launch.
Careers page.